DOI: 10.1055/s-00000069

Seminars in Liver Disease

Issue 04 · Volume 28 · November 2008 DOI: 10.1055/s-002-13670 Fatty Liver Disease Arun J Sanyal M.B.B.S. M.D.

FOREWORD

  • 337
    Sanyal, Arun J.:

    Fatty Liver Disease

  • 339
    Lazo, Mariana; Clark, Jeanne M.:

    The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective

  • 351
    Cheung, Onpan; Sanyal, Arun J.:

    Abnormalities of Lipid Metabolism in Nonalcoholic Fatty Liver Disease

  • 360
    Malhi, Harmeet; Gores, Gregory J.:

    Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease

  • 370
    Jou, Janice; Choi, Steve S.; Diehl, Anna Mae:

    Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease

  • 380
    Rubinstein, Eitan; Lavine, Joel E.; Schwimmer, Jeffrey B.:

    Hepatic, Cardiovascular, and Endocrine Outcomes of the Histological Subphenotypes of Nonalcoholic Fatty Liver Disease

  • 386
    Wieckowska, Anna; Feldstein, Ariel E.:

    Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive

  • 396
    Kashi, Maryam R.; Torres, Dawn M.; Harrison, Stephen A.:

    Current and Emerging Therapies in Nonalcoholic Fatty Liver Disease

  • 407
    Verna, Elizabeth C.; Berk, Paul D.:

    Role of Fatty Acids in the Pathogenesis of Obesity and Fatty Liver: Impact of Bariatric Surgery

  • 427
    Rafiq, Nila; Younossi, Zobair M.:

    Effects of Weight Loss on Nonalcoholic Fatty Liver Disease

    • DIAGNOSTIC PROBLEMS IN HEPATOLOGY

  • 434
    Lim, Kiat H.; Ward, Stephen C.; Roayaie, Sasan; Cohen, Emil; Schwartz, Myron; Fiel, M. Isabel; Thung, Swan N.:

    Multiple Inflammatory and Serum Amyloid A Positive Telangiectatic Hepatic Adenomas with Glycogenated Nuclei Arising in a Background of Nonalcoholic Steatohepatitis